DK1135514T3 - E1b-deleteret adenovirale shuttle-vektorer - Google Patents
E1b-deleteret adenovirale shuttle-vektorerInfo
- Publication number
- DK1135514T3 DK1135514T3 DK00907050T DK00907050T DK1135514T3 DK 1135514 T3 DK1135514 T3 DK 1135514T3 DK 00907050 T DK00907050 T DK 00907050T DK 00907050 T DK00907050 T DK 00907050T DK 1135514 T3 DK1135514 T3 DK 1135514T3
- Authority
- DK
- Denmark
- Prior art keywords
- shuttle vectors
- gene
- deleted adenoviral
- adenoviral shuttle
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11781499P | 1999-01-28 | 1999-01-28 | |
| PCT/US2000/002029 WO2000044922A1 (fr) | 1999-01-28 | 2000-01-26 | Vecteurs navettes adenoviraux comportant des genes deletes dans la region e1b |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1135514T3 true DK1135514T3 (da) | 2009-09-07 |
Family
ID=22374975
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK00907050T DK1135514T3 (da) | 1999-01-28 | 2000-01-26 | E1b-deleteret adenovirale shuttle-vektorer |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1135514B1 (fr) |
| AT (1) | ATE431421T1 (fr) |
| AU (1) | AU772544B2 (fr) |
| CA (1) | CA2360355A1 (fr) |
| CY (1) | CY1109288T1 (fr) |
| DE (1) | DE60042196D1 (fr) |
| DK (1) | DK1135514T3 (fr) |
| ES (1) | ES2325303T3 (fr) |
| PT (1) | PT1135514E (fr) |
| WO (1) | WO2000044922A1 (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030086903A1 (en) | 2001-11-02 | 2003-05-08 | Genvec, Inc. | Therapeutic regimen for treating cancer |
| EP1470233A1 (fr) * | 2002-02-01 | 2004-10-27 | Transgene S.A. | Vecteurs adenoviraux destines a moduler les activites cellulaires associees aux pod (domaines oncogeniques pml) |
| SI3029144T1 (sl) | 2009-03-02 | 2019-11-29 | Univ California | Tumorsko-selektivni adenovirus E1A in E1B mutanti |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5670488A (en) * | 1992-12-03 | 1997-09-23 | Genzyme Corporation | Adenovirus vector for gene therapy |
| US5801029A (en) * | 1993-02-16 | 1998-09-01 | Onyx Pharmaceuticals, Inc. | Cytopathic viruses for therapy and prophylaxis of neoplasia |
| US5981275A (en) * | 1997-04-14 | 1999-11-09 | Genzyme Corporation | Transgene expression system for increased persistence |
-
2000
- 2000-01-26 EP EP00907050A patent/EP1135514B1/fr not_active Expired - Lifetime
- 2000-01-26 DE DE60042196T patent/DE60042196D1/de not_active Expired - Lifetime
- 2000-01-26 WO PCT/US2000/002029 patent/WO2000044922A1/fr active IP Right Grant
- 2000-01-26 AU AU28613/00A patent/AU772544B2/en not_active Ceased
- 2000-01-26 DK DK00907050T patent/DK1135514T3/da active
- 2000-01-26 CA CA002360355A patent/CA2360355A1/fr not_active Abandoned
- 2000-01-26 PT PT00907050T patent/PT1135514E/pt unknown
- 2000-01-26 AT AT00907050T patent/ATE431421T1/de active
- 2000-01-26 ES ES00907050T patent/ES2325303T3/es not_active Expired - Lifetime
-
2009
- 2009-07-21 CY CY20091100776T patent/CY1109288T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE431421T1 (de) | 2009-05-15 |
| ES2325303T3 (es) | 2009-09-01 |
| DE60042196D1 (de) | 2009-06-25 |
| CA2360355A1 (fr) | 2000-08-03 |
| EP1135514A1 (fr) | 2001-09-26 |
| AU772544B2 (en) | 2004-04-29 |
| WO2000044922A1 (fr) | 2000-08-03 |
| PT1135514E (pt) | 2009-07-20 |
| AU2861300A (en) | 2000-08-18 |
| EP1135514B1 (fr) | 2009-05-13 |
| CY1109288T1 (el) | 2014-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT797676E (pt) | Vector adenoviral recombinante e metodos de utilizacao | |
| NO950939D0 (no) | Defektive adenovirusvektorer og deres anvendelse i gene-terapien | |
| DK1312679T3 (da) | Rekombinant MVA-virus og anvendelse deraf | |
| EP0710288A4 (fr) | Vecteurs adenoviraux pour le traitement de l'hemophilie | |
| IS4762A (is) | Samfallandi eitlaveiru genaferjukerfi og frumulínur | |
| EP0797436A4 (fr) | Nouveaux vecteurs adenoviraux, lignees cellulaires d'encapsidation, adenovirus recombines et procedes | |
| ATE295853T1 (de) | Langes pentraxin ptx3 enthaltende pharmazeutische zusammensetzungen | |
| CY1109288T1 (el) | Αδενοϊικοι φορεις οχηματα με απαλοιφη ε1β | |
| HUP9802587A2 (hu) | Glükózzal indukálható rekombináns virális vektor, ezt tartalmazó gyógyszerkészítmény és ezzel transzformált sejtek | |
| DE60237013D1 (de) | Replizierende adenovirus-vektoren | |
| DK1071805T3 (da) | Adenovirusvektorer til sygdomsbehandling | |
| DK1224310T3 (da) | Fremstilling af rekombinante adenovira og adenovirale banker | |
| WO2004033696A3 (fr) | Vecteurs adenoviraux recombinants et leurs applications | |
| WO2000022136A3 (fr) | Vecteurs adenoviraux recombinants presentant des effacements dans la region e1a | |
| 酒井佳夫 | Gene therapy for hepatocellular carcinoma using two recombinant adenovirus vectors with α-fetoprotein promoter and Cre/lox P system | |
| UA70909C2 (uk) | Рекомбінантний аденовірусний вектор, фармацевтична композиція, що його містить, та набір для зменшення проліферації пухлинних клітин | |
| BR0009666A (pt) | Adenovìrus recombinante e mutante derivado de adenovìrus bovino tipo 1 | |
| ADENOVIRUS | REPLICATION COMPETENT ADENOVIRUS | |
| MY157873A (en) | Recombinant mva virus, and the use thereof | |
| MY119381A (en) | Recombinant mva virus, and the use thereof | |
| MY134484A (en) | Recombinant mva virus, and the use thereof |